NXL
Price:
$3.82
Market Cap:
$49.13M
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was i...[Read more]
Industry
Medical - Devices
IPO Date
2022-09-16
Stock Exchange
NASDAQ
Ticker
NXL
According to Nexalin Technology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 49.05M. This represents a change of 463.96% compared to the average of 8.70M of the last 4 quarters.
The mean historical Enterprise Value of Nexalin Technology, Inc. over the last ten years is 11.84M. The current 49.05M Enterprise Value has changed 41.33% with respect to the historical average. Over the past ten years (40 quarters), NXL's Enterprise Value was at its highest in in the March 2022 quarter at 16.77M. The Enterprise Value was at its lowest in in the September 2022 quarter at -1495255.64.
Average
11.84M
Median
16.57M
Minimum
2.40M
Maximum
17.15M
Discovering the peaks and valleys of Nexalin Technology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 17.15M
Minimum Annual Increase = -63.48%
Minimum Annual Enterprise Value = 2.40M
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.40M | -60.29% |
2022 | 6.05M | -63.48% |
2021 | 16.57M | -2.70% |
2020 | 17.03M | -0.74% |
The current Enterprise Value of Nexalin Technology, Inc. (NXL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.34M
5-year avg
11.84M
10-year avg
11.84M
Nexalin Technology, Inc.’s Enterprise Value is greater than Ainos, Inc. (13.56M), less than Electromed, Inc. (238.10M), less than Armm Inc. (0), less than Surmodics, Inc. (554.56M), greater than Bluejay Diagnostics, Inc. (-3621459.00), greater than INVO Bioscience, Inc. (7.69M), greater than Motus GI Holdings, Inc. (-2500889.00), greater than IRIDEX Corporation (28.24M), greater than Aziyo Biologics, Inc. (40.84M), greater than Ainos, Inc. (13.56M), less than LENSAR, Inc. (77.17M), greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (3.12B), less than OrthoPediatrics Corp. (611.40M), less than Modular Medical, Inc. (55.20M), less than NeuroPace, Inc. (347.61M), greater than STRATA Skin Sciences, Inc. (22.14M), greater than Nemaura Medical Inc. (19.51M),
Company | Enterprise Value | Market cap |
---|---|---|
13.56M | $6.08M | |
238.10M | $251.96M | |
0 | $106.25K | |
554.56M | $561.12M | |
-3621459.00 | $1.89M | |
7.69M | $3.25M | |
-2500889.00 | $5.11K | |
28.24M | $29.95M | |
40.84M | $24.21M | |
13.56M | $6.45M | |
77.17M | $85.72M | |
40.81M | $8.18M | |
3.12B | $2.79B | |
611.40M | $637.85M | |
55.20M | $58.08M | |
347.61M | $289.53M | |
22.14M | $12.72M | |
19.51M | $8.07K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nexalin Technology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nexalin Technology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nexalin Technology, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Nexalin Technology, Inc. (NXL)?
What is the 3-year average Enterprise Value for Nexalin Technology, Inc. (NXL)?
What is the 5-year average Enterprise Value for Nexalin Technology, Inc. (NXL)?
How does the current Enterprise Value for Nexalin Technology, Inc. (NXL) compare to its historical average?